Pharmaceutical Network & Security Teams Improve Collaboration with Tool Consolidation

The biopharmaceutical company faced several challenges. They needed to increase visibility and network interconnectivity to support strategic mergers and acquisitions. They also aimed to consolidate tools and integrate operational processes of the network and security teams by implementing a holistic strategy to monitor performance under one vendor. The company also needed to provide the network and security teams with recommendations for additional instrumentation based on NetFlow analysis and identified gaps in packet-capture. They also had to manage additional instrumentation at co-los, regional offices, and new manufacturing sites as the business expands and the need for performance management visibility increases. Lastly, they had to support the migration of specific in-house applications to the cloud by monitoring traffic and analyzing packets before, during, and after the transition, and adapt reporting processes to meet strict compliance regulations in various geographic regions.

The customer is a global biopharmaceutical company known for its critical role in the development, manufacturing, and delivery of essential medicines. With over 30,000 global employees and billions of dollars in revenue each year, the company heavily depends on their digitally transformed enterprise network for everything from research, clinical trials, manufacturing, and sales and support. Their IT organization requires complete visibility of network and application performance. They have been a long-time NETSCOUT customer and have continuously evolved to leverage nGenius Enterprise Performance Management solutions to support mergers and acquisitions, adapt to global compliance requirements, and advance both performance management and security to improve their overall collaboration, cybersecurity posture, and business operations.